Search results
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 4 days agoToday, Pfizer and Moderna dominate the coronavirus vaccine market, making it difficult for a smaller player to gain much share, but an alliance with a...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 5 days agoWhy does Sanofi want the Novavax COVID vaccine? The Novavax COVID-19 vaccine, which is called...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 24 hours agoDemand for COVID products has been declining significantly over the past year. Pfizer experienced an 88% decline in revenue for its popular COVID vaccine...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 5 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 6 days agoThis analysis aims to determine whether Moderna's stock is significantly overvalued by examining its current market performance and intrinsic value. Founded in 2010 and going ...
There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy
The Telegraph via Yahoo News· 5 days agoHealth officials have been steadfast in their assurances. The risk of H5N1 bird flu jumping into...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 6 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 3 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 6 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 6 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
